Connect Biopharma Holdings (CNTB) Non-Current Assets (2020 - 2026)

Connect Biopharma Holdings has disclosed Non-Current Assets across 7 years of filings, most recently posting $4.8 million for Q2 2026.

• In Q2 2026, Non-Current Assets fell 2.41% year-over-year to $4.8 million; the TTM figure through Jun 2026 stood at $19.8 million (up 4.82% YoY), while the FY2025 annual figure was $5.1 million, up 19.04% from the prior year.
• Non-Current Assets came in at $4.8 million for Q2 2026 at Connect Biopharma Holdings, down from $5.0 million in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $37.6 million in Q2 2022 to a low of $4.3 million in Q4 2024.
• Average Non-Current Assets over 5 years is $8.8 million, with a median of $4.9 million recorded in 2025.
• Year-over-year, Non-Current Assets tumbled 83.79% in 2023 and grew 19.04% in 2025.
• Over 5 years, Non-Current Assets stood at $17.9 million in 2022, then slumped by 72.99% to $4.8 million in 2023, then fell by 10.35% to $4.3 million in 2024, then grew by 19.04% to $5.1 million in 2025, then declined by 5.77% to $4.8 million in 2026.
• Per Business Quant data, the three most recent Non-Current Assets figures were $4.8 million in Q2 2026, $5.0 million in Q1 2026, and $5.1 million in Q4 2025.